Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal End Point?
- Resource Type
- Correspondence
- Source
- In
Journal of Thoracic Oncology February 2022 17(2):e10-e12 - Subject
- Language
- ISSN
- 1556-0864